- Home
- QNME vs MYSE Comparison
QNME vs MYSE Comparison
Compare QNME & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNME | MYSE |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Telecommunications Equipment |
| Sector | Industrials | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 14.2M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QNME | MYSE |
|---|---|---|
| Price | $0.32 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 639.2K | 25.0K |
| Earning Date | 11-23-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 47.83 | ★ 56.64 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,850,681.00 | $550.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 111.79 | 26.15 |
| 52 Week Low | $0.26 | $1.16 |
| 52 Week High | $1.40 | $11.54 |
Technical Indicators
Market Signals| Indicator | QNME | MYSE |
|---|---|---|
| Relative Strength Index (RSI) | 39.77 | 26.28 |
| Support Level | $0.28 | N/A |
| Resistance Level | $0.43 | $1.66 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 6.34 | 7.17 |
Price Performance
Historical ComparisonAbout QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
About MYSE Myseum Inc.
Myseum.AI Inc is an integrate proprietary privacy-first artificial intelligence (AI) and social media technology company. The Company is developing privacy-first agentic localized AI agents to assist in managing personal media such as photos, videos and messages, while maintaining privacy.